Ignite Creation Date:
2024-05-06 @ 8:22 PM
Last Modification Date:
2024-10-26 @ 3:26 PM
Study NCT ID:
NCT06350344
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-04-11
First Post:
2024-03-31
Brief Title:
Smart Technology Facilitated Patient-centered Venous Thromboembolism Management
Sponsor:
Navy General Hospital Beijing
Organization:
Navy General Hospital Beijing
Study Overview
Official Title:
Smart Technology Facilitated Patient-centered Venous Thromboembolism Management A Multicenter Cohort Study
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
SmaVTE-COR
Brief Summary:
Smart technologies such as wearable devices mobile technologies and artificial intelligence are being investigated for use in health management These technologies have the potential to be applied in disease pre-warning decision-making support health education and healthcare maintenance They are expected to address the challenges in managing thrombosis improve access to high-quality medical resources in various regions and enhance the development of a network for thrombosis rescue and treatment prevention
The objective of this study is to observe the long-term effect of mobile venous thromboembolism application mVTEA based patient-centered management of venous thromboembolism VTE on thromboprophylaxis and establish a foundation of evidence for managing patients with high-risk VTE
The objective of this study is to observe the long-term effect of mobile venous thromboembolism application mVTEA based patient-centered management of venous thromboembolism VTE on thromboprophylaxis and establish a foundation of evidence for managing patients with high-risk VTE
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None